Increased funding and health care reform are key to drug treatment accessibility

Federal funds for substance-use treatment and prevention in FY2013 were approximately $9.2 billion and are forecast to rise to $10.9 billion in FY2015, which represents an increase of 18.4 percent over three years. While this is promising, the amount of funds spent on both law enforcement and interdiction are not decreasing significantly. If there were to be a genuine shift from enforcement to treatment, I would expect to see enforcement efforts decrease significantly, providing even more increases for treatment and prevention. Continue Reading

Drug war fatigue, a sympathetic user population and shifting public attitudes drive current drug treatment trends

Lately, the drug policy landscape has been awash with calls for decriminalization (mostly for marijuana) and expanded drug rehabilitation. The treatment conversation has grown louder as increases in prescription opioid and heroin overuse and overdose deaths have made national headlines. The Centers for Disease Control and Prevention found that from 2010 to 2012 the heroin overdose rate doubled in 28 states. Less publicized was the finding that prescription opioids accounted for twice as many overdose deaths as heroin during that time. Continue Reading

The future of treatment in drug policy: Stigma remains a serious problem

The first three priorities outlined in the strategy recently established by President Barack Obama’s Office of National Drug Control Policy — prevention, treatment and criminal justice system reforms — may seem like a progressive breakthrough in our nation’s lengthy drug war. In fact, since 1971, each of these three strategies has factored into presidential drug policy with varying degrees of emphasis and alternating tactics for accomplishing each one. In contrast, the fourth strategy set by today’s ONDCP — to lift the stigma associated with those suffering from substance use disorders — is unprecedented. Continue Reading